__NUXT_JSONP__("/drugs/Atrasentan_Hydrochloride", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"195733-43-8",chebiId:"",chemicalFormula:"C29H38N2O6.ClH",definition:"The orally available hydrochloride salt of pyrrolidine-3-carboxylic acid with potential antineoplastic activity.  As a selective antagonist of the endothelin-A (ETA) receptor, atrasentan binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation.",fdaUniiCode:"E4G31X93ZA",identifier:"C1779",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C28334"],synonyms:["(+)-A 127722","(2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid Monohydrochloride","ABT-627","ATRASENTAN HYDROCHLORIDE",b,"Xinlay"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAtrasentan_Hydrochloride",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Atrasentan_Hydrochloride","Atrasentan Hydrochloride","2021-10-30T13:36:31.663Z")));